Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VET | PAX |
|---|---|---|
| Price | $11.73 | $11.10 |
| Change today | ▲ 0.43% | ▲ 8.72% |
| Market cap | $1.79B | $1.79B |
| Return, 3 months | +30.6% | +1.7% |
| Return, year to date | +44.1% | -27.3% |
| Return, 1 year | +41.7% | -18.1% |
| P/E (TTM) | -5.8 | 24.9 |
| P/B | 1.2 | 3.2 |
| P/E percentile vs own 5y | – | 73rd |
| Dividend yield | 3.18% | 5.41% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +14.7% | -0.9% |
| Analyst buy share | 20% | 0% |
| RSI (14) | 45 | 62 |
| 30-day volatility | 36.0% | 35.1% |
| Max drawdown, 1 year | -38.9% | -40.9% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Hold | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
